| Code | Description | Claims | Beneficiaries | Total Paid |
| X4011 |
State-specific procedure code |
4,402 |
3,923 |
$971K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,048 |
3,580 |
$480K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,929 |
1,592 |
$257K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,124 |
4,620 |
$246K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,911 |
6,451 |
$241K |
| 80053 |
Comprehensive metabolic panel |
7,805 |
5,879 |
$202K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,895 |
2,834 |
$150K |
| X4003 |
|
985 |
688 |
$117K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
784 |
725 |
$90K |
| 81001 |
|
2,484 |
1,898 |
$63K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,333 |
1,283 |
$63K |
| 87081 |
|
155 |
143 |
$37K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,633 |
1,377 |
$32K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,143 |
815 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,835 |
1,432 |
$26K |
| 94375 |
|
569 |
482 |
$25K |
| 71045 |
Radiologic examination, chest; single view |
910 |
640 |
$23K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
136 |
115 |
$14K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
3,213 |
2,659 |
$12K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
190 |
120 |
$12K |
| 83735 |
|
780 |
519 |
$10K |
| 36415 |
Collection of venous blood by venipuncture |
424 |
348 |
$10K |
| J3490 |
Unclassified drugs |
2,201 |
1,595 |
$10K |
| A0425 |
Ground mileage, per statute mile |
734 |
596 |
$10K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
121 |
116 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
81 |
54 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
120 |
93 |
$7K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
34 |
24 |
$6K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
25 |
13 |
$5K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
51 |
39 |
$4K |
| 83690 |
|
131 |
106 |
$3K |
| 11721 |
|
1,247 |
888 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
179 |
161 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
306 |
293 |
$3K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
46 |
40 |
$3K |
| 82728 |
|
339 |
250 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
108 |
68 |
$2K |
| 84484 |
|
514 |
313 |
$2K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
46 |
37 |
$2K |
| Y7506 |
|
55 |
28 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
14 |
13 |
$2K |
| 83605 |
|
65 |
54 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
122 |
116 |
$2K |
| 36591 |
|
21 |
12 |
$1K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
60 |
57 |
$989.24 |
| 83880 |
|
90 |
50 |
$956.65 |
| 80061 |
Lipid panel |
165 |
137 |
$876.74 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
18 |
13 |
$849.94 |
| 93298 |
|
99 |
63 |
$793.40 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
180 |
174 |
$675.00 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
15 |
12 |
$602.84 |
| 93294 |
|
33 |
25 |
$238.79 |
| 82550 |
|
121 |
74 |
$230.76 |
| 82150 |
|
67 |
56 |
$148.04 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
18 |
17 |
$139.84 |